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Four chloroacetamide herbicides, acetochlor
[2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-
methylphenyl)acetamide], alachlor [2-chloro-
N-methoxymethyl-N-(2,6-diethylphenyl)-
acetamide], butachlor [N-(butoxymethyl)-2-
chloro-N-(2,6-diethylphenyl)-acetamide],
and metolachlor [2-chloro-N-(2-ethyl-6-
methylphenyl)-N-(2-methoxy-1-
methylethyl)acetamide] (Figure 1), are widely
used in the production of several economical-
ly important crops. Alachlor has an estimated
annual use of 25 million pounds per year in
the production of corn, soybeans, peanuts,
and grain sorghum, and acetochlor has an
annual estimated use of 35 million pounds
per year, mostly in the production of corn.
Metolachlor has an annual estimated use of
65 million pounds per year in the production
of corn and soybeans and also for nonagricul-
tural use in rights-of-way (1). Butachlor is
not used in the United States but it is used in
rice-producing countries. 
The mutagenicity of acetochlor, alachlor,
butachlor, and metolachlor has been
reviewed thoroughly by Dearﬁeld et al. (2).
Both acetochlor (3–5) and alachlor (6–9)
have been found to cause increases in nasal
tumors in rats, whereas metolachlor produces
an increase in the incidence of liver tumors
(10–13). Butachlor was found to be muta-
genic in primary rat tracheal epithelial cells
and Chinese hamster ovarian cells (14,15).
The hypothesized mechanism of carcino-
genicity is bioactivation of these herbicides
through several steps, ultimately leading to
the formation of a DNA-reactive metabolite
(Figure 2), 2-methyl-6-ethylbenzoquinone
imine (MEBQI) for acetochlor and meto-
lachlor and 2,6-diethylbenzoquinone imine
(DEBQI) for alachlor and butachlor.
Acetochlor and metolachlor have been shown
to form MEBQI, and alachlor and butachlor
have been shown to form DEBQI in rats that
were treated with these herbicides (16). 
The Food Quality Protection Act of
1996 (17) includes a mandate for the U.S.
Environmental Protection Agency (U.S.
EPA) to consider cumulative risks of pesti-
cides that have a common mechanism of
action. The carcinogenic potential of the
chloroacetamide herbicides, combined with
the presence of a common metabolic 
activation pathway leading to the formation
of a putative ultimate carcinogenic metabo-
lite, suggests that these herbicides have a
common mechanism of carcinogenicity. If
humans are able to metabolize each of these
herbicides to the DNA-reactive metabolite,
then the risk of these herbicides should be
combined into the same risk cup. However,
if humans are unable to bioactivate each of
these herbicides, then the risk of each pesti-
cide should be considered on an individual
basis.
There are two main purposes of the 
present study: a) to determine the rates of
metabolism of acetochlor and metolachlor to
2-chloro-N-(2-methyl-6-ethylphenyl)acetamide
(CMEPA), butachlor to 2-chloro-N-(2,6-
diethylphenyl)acetamide (CDEPA), CMEPA
to 2-methyl-6-ethylaniline (MEA), CDEPA
to 2,6-diethylaniline (DEA), MEA to 2-
methyl-6-ethylaminophenol, and DEA to
2,6-diethylaminophenol using both rat and
human liver microsomes; and b) to determine
which human cytochrome P450 isoforms are
responsible for the metabolism of these com-
pounds. With this information, a more accu-
rate risk assessment for these herbicides may
be possible.
Materials and Methods
Chemicals. We purchased acetochlor,
butachlor, and metolachlor from Chem
Services (West Chester, PA); β -nicotinamide
adenine dinucleotide phosphate (NADP), D-
glucose-6-phosphate, and glucose-6-phos-
phate dehydrogenase from Sigma (St. Louis,
MO); and diethylaniline, methylethylani-
line, and chloroacetyl chloride from Aldrich
(Milwauke, WI). All other chemicals were
the highest grade available and purchased
from regional suppliers.
Metabolite synthesis. CMEPA was syn-
thesized in 67% yield by acylation of
methylethylaniline with chloroacetyl chlo-
ride in refluxing ethyl acetate using the
method of Nesnow et al. (18). The structure
of CMEPA was confirmed using nuclear
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Acetochlor [2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methyl-phenyl)-acetamide], alachlor 
[N-(methoxymethyl)-2-chloro-N-(2,6-diethyl-phenyl)acetamide], butachlor [N-(butoxymethyl)-2-
chloro-N-(2,6-diethyl-phenyl)acetamide], and metolachlor [2-chloro-N-(2-ethyl-6-methylphenyl)-
N-(2-methoxy-1-methylethyl) acetamide] are pre-emergent herbicides used in the production of
agricultural crops. These herbicides are carcinogenic in rats: acetochlor and alachlor cause tumors
in the nasal turbinates, butachlor causes stomach tumors, and metolachlor causes liver tumors. It
has been suggested that the carcinogenicity of these compounds involves a complex metabolic acti-
vation pathway leading to a DNA-reactive dialkylbenzoquinone imine. Important intermediates in
this pathway are 2-chloro-N-(2,6-diethylphenyl)acetamide (CDEPA) produced from alachlor and
butachlor and 2-chloro-N-(2-methyl-6-ethylphenyl)acetamide (CMEPA) produced from acetochlor
and metolachlor. Subsequent metabolism of CDEPA and CMEPA produces 2,6-diethylaniline
(DEA) and 2-methyl-6-ethylaniline (MEA), which are bioactivated through para-hydroxylation
and subsequent oxidation to the proposed carcinogenic product dialkylbenzoquinone imine. The
current study extends our earlier studies with alachlor and demonstrates that rat liver microsomes
metabolize acetochlor and metolachlor to CMEPA (0.065 nmol/min/mg and 0.0133
nmol/min/mg, respectively), whereas human liver microsomes can metabolize only acetochlor to
CMEPA (0.023 nmol/min/mg). Butachlor is metabolized to CDEPA to a much greater extent by
rat liver microsomes (0.045 nmol/min/mg) than by human liver microsomes (< 0.001
nmol/min/mg). We have determined that both rat and human livers metabolize both CMEPA to
MEA (0.308 nmol/min/mg and 0.541 nmol/min/mg, respectively) and CDEPA to DEA (0.350
nmol/min/mg and 0.841 nmol/min/mg, respectively). We have shown that both rat and human
liver microsomes metabolize MEA (0.035 nmol/min/mg and 0.069 nmol/min/mg, respectively)
and DEA (0.041 nmol/min/mg and 0.040 nmol/min/mg, respectively). We have also shown that
the cytochrome P450 isoforms responsible for human metabolism of acetochlor, butachlor, and
metolachlor are CYP3A4 and CYP2B6. Key words: chloroacetamide herbicides, human
cytochrome P450, in vitro metabolism. Environ Health Perspect 108:1151–1157 (2000). [Online
7 November 2000]
http://ehpnet1.niehs.nih.gov/docs/2000/108p1151-1157coleman/abstract.htmlmagnetic resonance (NMR) (Figure 3).
CDEPA was synthesized as previously
reported (19).
Microsome preparation. Microsomes
were prepared from male Long-Evans rats
(Charles River Laboratories, Raleigh, NC).
Brieﬂy, the animals were sacriﬁced and the
livers were removed, weighed, and placed in
ice-cold 50 mM potassium phosphate (pH
7.5) containing 0.1 mM EDTA and 1.15%
potassium chloride. The livers were minced
with scissors, homogenized with a Polytron
homogenizer (Kinematica, Kriens-Lucern,
Switzerland), and centrifuged at 10,000g for
15 min. The supernatant was filtered
through glass wool and centrifuged at
100,000g for 1 hr. The microsomal pellet
was resuspended in 50 mM potassium phos-
phate (pH 7.5) containing 0.1 mM EDTA
and 0.25 M sucrose, and aliquots were
stored at –80°C until use. We determined
protein concentration using a BCA kit
(Pierce Chemical Co., Rockford, IL) prior to
use. Male human liver microsomes (20
mg/mL protein) were purchased from
Xenotech, LLC (Kansas City, KS). 
Human CYP isoforms. We purchased
human CYP1A1, 1A2, 2B6, 2D6, 2E1, and
3A4 from Gentest Corporation (Woburn,
MA). These isoforms are derived from micro-
somes of lymphoblastoma cell lines transfect-
ed with human cDNA for each isoform
individually. Isoforms tested in our laboratory
using assays suggested by Gentest had activi-
ties similar to those reported by Gentest.
Acetochlor, butachlor, metolachlor,
MEA, and DEA metabolism. For the metab-
olism of each substrate by liver microsomes,
CYP1A2, 2B6, 2D6, 2E1, or 3A4 isoforms,
the substrate (50 µM) was incubated with
the corresponding system (1 mg protein for
the isoforms, human liver microsomes, and
rat liver microsomes) in the presence of an
NADPH regenerating system (0.25 mM
NADP+, 2.5 mM glucose-6-phosphate, and
2.0 U glucose-6-phosphate dehydrogenase)
in 0.1 M phosphate buffer, 0.005 M MgCl2
at pH 7.4 for up to 1 hr. For substrate
metabolism by CYP2A6, we incubated the
substrate (50 µM) with the isoform (1 mg
protein) in the presence of an NADPH
regenerating system (0.25 mM NADP+, 2.5
mM glucose-6-phosphate, and 2.0 U glu-
cose-6-phosphate dehydrogenase) in 0.1 M
Tris buffer, 0.005 M MgCl2 at pH 7.5 for
up to 1 hr. Aliquots were removed at time
points up to 20 min and added to an equal
volume of ice-cold methanol. The solution
was then vortexed and centrifuged. The
supernatant was injected directly onto an
HPLC consisting of a reversed-phase col-
umn (Prodigy C18, 250 × 3.9 mm;
Phenomenex, Torrance, CA) with a mobile
phase of 55:45 (v/v) water:acetonitrile with
UV detection at 238 nm. The limit of detec-
tion for CMEPA, CDEPA, MEA, and DEA
was 0.0625 nmol. Rates of CMEPA or
CDEPA formation were calculated against a
standard curve for either CDEPA or
CMEPA that we ran on the same day. Rates
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Figure 1. Chemical structure of acetochlor,
alachlor, butachlor, and metolachlor.
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Figure 2. Metabolic pathway for the bioactivation
of chloroacetamide herbicides. Acetochlor: R1,
CH2CH3; R2, CH3; R3, CH2OCH2CH3. Alachlor: R1,
CH2CH3; R2, CH2CH3; R3, CH2OCH3. Butachlor: R1,
CH2CH3; R2, CH2CH3; R3, CH2O(CH2)3CH3. Metolachlor:
R1, CH2CH3; R2, CH3; R3, CH3CHCH2OCH3. CDEPA: R4,
CH2CH3; R5, CH2CH3. CMEPA: R4, CH2CH3; R5, CH3.
DEA: R6, CH2CH3; R7, CH2CH3. MEA: R6, CH2CH3; R7,
CH3. DEAOH: R8, CH2CH3; R9, CH2CH3. MEAOH: R8,
CH2CH3; R9, CH3. 
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Figure 3. 1H-NMR spectra of CMEPA. of MEA or DEA oxidation were calculated
as the loss of substrate against a standard
curve for either MEA or DEA that we ran
on the same day. 
CMEPA and CDEPA Metabolism. For
the metabolism of each of these compounds
by rat and human liver microsomes, the sub-
strate (50 µM) was incubated with protein (2
mg for rat liver microsomes and 0.2 mg for
human liver microsomes) in 0.1 M phosphate
buffer, 0.005 M MgCl2, pH 7.4, for up to 1
hr. Aliquots were removed at time points up
to 1 hr and added to an equal volume of ice-
cold methanol. The solution was then vor-
texed and centrifuged. The supernatant was
injected directly onto an HPLC consisting of
a reversed phase column (Prodigy C18, 250 ×
4.6 mm; Phenomenex) with a mobile phase
of 55:45 (v/v) water:acetonitrile with UV
detection at 238 nm. Rates of MEA or DEA
formation were calculated against a standard
curve for either MEA or DEA ran on the
same day. The Km and Vmax values for rat and
human liver microsomal arylamidase toward
CDEPA was calculated using a Lineweaver-
Burke double reciprocal plot.
Results
We synthesized CMEPA by following the
method of Nesnow (18) for CDEPA synthe-
sis. The structure of CMEPA was conﬁrmed
using 1H-NMR spectroscopy (Figure 3).
Figures 4 and 5 summarize the results of
rat and human liver microsomal metabolism
of acetochlor, alachlor, butachlor, meto-
lachlor, CDEPA, CMEPA, DEA, and MEA.
As previously observed for alachlor (19), the
most striking differences in the metabolism
were observed between species in the initial
step leading to the production of CDEPA
(butachlor) or CMEPA (acetochlor or meto-
lachlor). For acetochlor, CMEPA produc-
tion by rat liver microsomes was similar to
that of human liver microsomes (0.065
nmol/min/mg and 0.023 nmol/min/mg,
respectively), whereas a more pronounced
difference was observed for butachlor (0.045
nmol/min/mg and < 0.0015 nmol/min/mg,
respectively). In contrast, rat liver microsomes
metabolized metolachlor to CMEPA at a rate
of 0.013 nmol/min/mg, whereas human liver
microsomes were unable to metabolize meto-
lachlor to CMEPA (Figures 6 and 7). When
acetochlor, alachlor, butachlor, and meto-
lachlor were incubated with either rat or
human liver microsomes for up to 20 min, we
were not able to detect any aniline, DEA, or
MEA formation. This suggests that any
CDEPA or CMEPA produced in this time
was either not being metabolized to the corre-
sponding aniline by the aryl amidase or
metabolized so slowly as to preclude detection. 
Other differences in the metabolism relat-
ing to the subsequent steps in the pathway
leading to the formation of the DABQI were
minimal between species. Although both rats
and humans metabolized CDEPA to DEA
(Figures 8 and 9, respectively), the human
liver microsomal arylamidase was more active
toward either CDEPA or CMEPA than the
rat liver microsomal arylamidase. These species
differences are reﬂected by the different Km
and Vmax values obtained from rat liver micro-
somal arylamidase (230 µM and 1.2
nmol/min/mg, respectively) and human liver
microsomal arylamidase values (470 mM and
9.1 nmol/min/mg, respectively). We observed
no major differences between species in the
metabolism of DEA or MEA to their respec-
tive hydroxylated products (Figures 4 and 5). 
We also determined that acetochlor,
butachlor, and metolachlor are metabolized
by CYP2B6 and 3A4. In previous work (19),
we demonstrated that alachlor was metabo-
lized by CYP3A4, but not by several other
isoforms including CYP2B6. Reanalysis of
CYP2B6 with respect to alachlor revealed
that alachlor is a substrate for this isoform. 
CYP2B6 metabolizes the substrates to
only one product, whereas CYP3A4 is able
to metabolize the substrates to multiple
products, as shown for metolachlor in
Figures 10 and 11. CYP2B6 metabolized
both alachlor and butachlor to CDEPA, ace-
tochlor to CMEPA, and metolachlor to an
unknown metabolite. Because CYP2B6 N-
dealkoxylated acetochlor, alachlor, and
butachlor, we thought that the unknown
metabolite was a derivative of the possible
N-dealkoxylated product. To determine the
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Figure 4. Comparison of the metabolism of alachlor, butachlor, CDEPA, and DEA between rat and human
liver microsomes. Abbreviations: RLM, rat liver microsomes; HLM, human liver microsomes. Rates are
expressed as nmol/min/mg ± SEM. 
*Data from Coleman et al. (19).
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Nstructure of this metabolite we used liquid
chromatography/mass spectrometry with
Atmospheric Pressure Chemical Ionization
(APCI) in the positive mode. We were able to
determine that the metabolite had a base peak
of 270 m/z while metolachlor had a base peak
of 284 m/z, suggesting O-demethylation of
metolachlor leading to the formation of 2-
chloro-N-(2-ethyl-6-methylphenyl)-N-(2-
hydroxy-1-methylethyl)-acetamide.
Discussion
The U.S. EPA has classiﬁed alachlor and ace-
tochlor as probable human carcinogens and
metolachlor as a possible human carcinogen;
there has been no classiﬁcation of butachlor
at present. The classiﬁcation of alachlor and
acetochlor as probable human carcinogens
and metolachlor as a possible human carcino-
gen are based on the findings of increased
incidence of tumors in rats chronically
administered these herbicides. One proposed
mechanism of carcinogenicity for acetochlor,
alachlor, and metolachlor involves their
bioactivation to a DNA-reactive metabolite.
Although metabolism of acetochlor, alachlor,
butachlor, and metolachlor has been exten-
sively studied in rats, there has been minimal
work examining the metabolism of these her-
bicides in humans. Earlier work demonstrat-
ed that metabolites of alachlor formed DNA
adducts (20) as well as DNA single strand
breaks (21). Recent studies have indicated
that rats are able to metabolize acetochlor,
alachlor, butachlor, and metolachlor to their
putative DNA-reactive benzoquinone imine
products (16).
The formation of DNA-reactive metabo-
lites from acetochlor, alachlor, butachlor, and
metolachlor is dependent on the production
of either DEA or MEA. There are two possi-
ble ways for these anilines to be formed:
through the formation of CDEPA/CMEPA
by P450 followed by an arylamidase reaction,
or through conjugation of the herbicide with
glutathione by displacement of the chlorine
atom and subsequent amide hydrolysis. Li et
al. (22) suggested that the formation of DEA
from alachlor in rats and monkeys is depen-
dent upon the conjugation of alachlor to
glutathione, consequent enterohepatic circu-
lation of this reduced glutathione (GSH)
conjugate, conversion of the GSH conjugate
to the secondary methylsulfide, and amide
hydrolysis of the secondary methylsulﬁde to
DEA (22). It was suggested that because this
occurs in monkeys at a slow rate, this conver-
sion would also occur at a slow rate in
humans. Heydens et al. (23) showed that
when an in vitro model for rats and humans
is used, alachlor is conjugated to GSH at a
rate in humans approximately four times less
than in rats (23). With this information it
appears that alachlor may not be as good a
substrate with human GSH transferases as
compared to rat GSH transferases. Because
conjugation of alachlor with GSH occurs
slowly in humans, alachlor may be available
as a substrate for human P450s leading to the
formation of CDEPA.
In the current study, incubations of the
parent herbicides with liver microsomes
resulted in major differences between rats
and humans in the formation of CDEPA or
CMEPA. Our data also indicate that the ary-
lamidase activity in microsomal tissues of
both organisms is not rate-limiting with
respect to DEA or MEA formation. It could
be argued that the presence of the arylami-
dase in microsomes effectively removes
CDEPA or CMEPA as quickly as it is
formed, resulting in apparently low steady-
state levels of CDEPA or CMEPA product
formation. However, formation of DEA or
MEA was not observed during microsomal
incubations up to 20 min, and in very low
amounts in incubations exceeding 1 hr. This
may be due to the fact that the concentra-
tions of CDEPA or CMEPA were well below
saturation; thus further metabolism under
the conditions of the assay would be expected
to be slow. This is supported by the high Km
values reported for the rat and human ary-
lamidases (231 and 473 µM, respectively).
For acetochlor, the rate of metabolism to
CMEPA by human liver microsomes is
approximately one-third the rate observed in
rat liver microsomes. Although rat liver
microsomes metabolized metolachlor to
CMEPA at a rate approximately one-fifth
the rate observed for acetochlor, human liver
microsomes were unable to form CMEPA
from metolachlor. Likewise in human liver
microsomes, the rate of metabolism of
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Figure 5. Comparison of the metabolism of acetochlor, metolachlor, CMEPA, and MEA between rat and
human liver microsomes. Abbreviations: HLM, human liver microsomes; ND, none detected; RLM, rat liver
microsomes. Rates are expressed as nmol/min/mg ± SEM.butachlor to CDEPA was significantly less
than the rate observed with rat liver micro-
somes. Our recent studies with alachlor also
demonstrated low rates of metabolism to
CDEPA by human liver microsomes as com-
pared to the rate for rat liver microsomes
(19). The lower rates of CDEPA formation
from alachlor and butachlor by human liver
microsomes suggest that there would be less
DEA formed. Metolachlor is not metabo-
lized to CMEPA by human liver micro-
somes, which suggests that no MEA would
be formed even if metolachlor were conju-
gated to GSH. Feng et al. (24) showed that
for compounds to be a substrate of the
microsomal arylamidase, there cannot be any
substitution on the nitrogen. 
The ability of these herbicides to be sub-
strates for both CYP2B6 and CYP3A4 is
supported by the molecular modeling of
CYP 3A4 by Szklarz and Halpert (25). They
showed that some, but not all, of the
residues that are important in the interaction
of substrates with CYP3A are also located
within rat CYP2B. This may explain why
CYP2B6 produces only one metabolite, but
CYP3A4 produces multiple metabolites. In
our previous work using a less sensitive
method, we reported that alachlor was a sub-
strate for CYP3A4 only (19) but here we
show that alachlor is metabolized by
CYP2B6.
It also appears that there are some struc-
tural requirements for the metabolism of
these herbicides. Because metolachlor is O-
demethylated and not N-dealkoxylated, this
suggests that the N-alkoxy group cannot be
bulky. Also, the slow rate of metabolism of
butachlor to CDEPA suggests that the
length of the alkoxy group needs to be less
than six atoms. The greater metabolism of
acetochlor to CMEPA as compared to the
metabolism of alachlor to CDEPA suggests
that the methyethyl phenyl group is more
readily metabolized than the diethyl phenol
group in these pesticides.
The liver microsomal arylamidase respon-
sible for the metabolism of both CDEPA and
CMEPA is also a carboxylesterase. There are
several isoforms of carboxylesterases that have
been classiﬁed based on substrate speciﬁcity
and their isoelectric point (26). We have
shown that there are differences in the ability
of the rat and human liver microsomal 
arylamidase to cleave CDEPA and CMEPA.
The human liver microsomal arylamidase
appears to metabolize CDEPA at a rate twice
that of the rat liver microsomal arylamidase,
whereas the activity of both the human and
rat liver microsomal arylamidase toward
CMEPA appear similar. The differences we
have shown could be due to isoform speciﬁci-
ty of the carboxylesterases between rats and
humans. Previous work has suggested that
human liver microsomes have very little activ-
ity toward CDEPA (23). We have clearly
shown that both human and rat liver micro-
somes have activity toward CDEPA. To
ensure that this activity was not due to
nonenzymatic hydrolysis, we used negative
controls in which the substrate was incubated
in buffer without microsomes. No DEA was
produced in these negative controls.
DEA is metabolized by rat liver micro-
somes to p-hydroxy-diethylaniline (27).
Heydens et al. (23) showed that there are sig-
niﬁcant differences in the oxidation of DEA
between rat and human liver microsomes,
with rat liver microsomes having a 7–10-fold
greater activity toward DEA than human
liver microsomes. Our results contrasted 
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Figure 6. Metabolism of metolachlor (50 µM) by rat liver microsomes (1 mg pro-
tein) at 37°C for 20 min. AU, absorbance units. Peaks A, B, and C are unknown
metabolites. 
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Figure 7. Metabolism of metolachlor (50 µM) by human liver microsomes (1 mg
protein) at 37°C for 20 min. AU, absorbance units. Peaks A and C are unknown
metabolites; peak B is 2-chloro-N-(2-ethyl-6-methylphenyl)-N-(2-hydroxy-1-
methyl-ethyl)acetamide.
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35.00 40.00significantly in that we found very similar
rates of metabolism of DEA by rat and
human liver microsomes. However, we were
able to see a difference in the rate of metab-
olism of MEA by rat and human liver
microsomes, with human liver microsomes
having a rate of MEA oxidation almost twice
that of rat liver microsomes.
The regulations of the Food Quality
Protection Act of 1996 (17) suggest that
chemicals possessing the same mechanism of
action should be combined into an aggregate
group known as a risk cup. The combined
human exposure of chemicals in the same
risk cup must not exceed a limit yet to be
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Figure 8. Metabolism of CDEPA (50 µM) by rat liver microsomes (2 mg protein)
at 37°C for 20 min. AU, absorbance units.
Figure 9. Metabolism of CDEPA (50 µM) by human liver microsomes (0.2 mg
protein) at 37°C for 20 min. AU, absorbance units.
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Figure 10. Metabolism of metolachlor (50 µM) by human CYP2B6 (1 mg protein)
at 37°C for 20 min. AU, absorbance units. Peak B is 2-chloro-N-(2-ethyl-6-
methylphenyl)-N-(2-hydroxy-1-methylethyl)acetamide. 
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Figure 11. Metabolism of metolachlor (50 µM) by human CYP3A4 (1 mg protein)
at 37°C for 20 min. AU, absorbance units. Peaks A and C are unknown metabo-
lites; peak B is 2-chloro-N-(2-ethyl-6-methylphenyl)-N-(2-hydroxy-1-methyl-
ethyl)acetamide. 
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Cdetermined. It has been suggested that the
chloroacetanilide herbicides should belong
in the same risk cup based upon the pro-
posed mechanism of carcinogenicity being
bioactivation to the corresponding DABQI
(28). We have shown, however, that there
are significant differences in the ability of
human liver microsomes to metabolize ace-
tochlor, alachlor, butachlor, and metolachlor
compared to rat liver microsomes. This
implies that these herbicides may be divided
into separate risk cups.
One aspect that the present study does
not address is the extrahepatic metabolism of
these compounds. Wetmore et al. (29)
demonstrated that alachlor is mutagenic in
the Ames assay, but only in the presence of
Long-Evans olfactory mucosal S9. Further
work examining the possible metabolism of
the compounds used in the present study by
human nasal tissue or other extrahepatic tis-
sue would provide more insight for this issue.
In summary, our work using human
liver microsomes suggests that metolachlor
cannot be metabolized to CMEPA, a neces-
sary precursor for the formation of the puta-
tive ultimate carcinogen MEBQI. Thus,
based on our work with human liver micro-
somes, metolachlor may not be genotoxic to
humans. Alachlor and butachlor are metabo-
lized to CDEPA at substantially lower rates
by human liver microsomes than by rat liver
microsomes, which suggests that alachlor
and butachlor may have minimal human
genotoxicity. However, human liver micro-
somes metabolize acetochlor to CMEPA at a
similar rate to that of rat liver microsomes,
and subsequent metabolic rates of CMEPA
and MEA with human liver microsomes
exceed those of rat liver microsomes, sug-
gesting that acetochlor has the greatest
potential to be genotoxic to humans.
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